Prevention responses Scientific Prevention and early Early detection, Evaluation of Assessing the Priority 4 and evaluation in identification of risk drug testing and preventive measures impact of the specific focus prevention (BFPN, uses of drugs brief interventions (DWP, 1996) decriminalization expected due to 2001) particularly for (DPA, 2011) law (PP, 2005-12) financial pressures teenagers and young (CGDRS, 2010) adults (FGP, Research on the HIV/AIDS Evaluating the prevention of the infectious diseases effectiveness of drug use (BCD, testing and interventions 2010) Evaluation studies on counselling (DPA, the field of limitation 2011) (Scottish drug of drug use (FGP, 2008-2011) strategy document 2008 ; drug strategy document Research into public 2008-2018) policies and in prevention responses in particular (FGP, 2013-17) Treatment responses Priority 4 and Scientific Promising medicines Promising Effectiveness and Assessing the specific focus evaluation in and new therapeutic medications (DPA, harmfulness of impact of the expected due to prevention (BFPN, strategies (FGP, 2011) prescribing heroin on decriminalization financial pressures 2001 medical ground to law(PP, 2005-12) (CGDRS, 2010) any type of addict Transcranic (DWP, 1996) magnetic
Prevention responses Scientific evaluation in prevention (BFPN, 2001) Research on the prevention of the drug use (BCD, 2010) Prevention and early identification of risk uses of drugs particularly for teenagers and young adults (FGP, Evaluation studies on the field of limitation of drug use (FGP, 2008-2011) Research into public policies and in prevention responses in particular (FGP, 2013-17) Early detection, drug testing and brief interventions (DPA, 2011) HIV/AIDS infectious diseases testing and counselling (DPA, 2011) Evaluation of preventive measures (DWP, 1996) Assessing the impact of the decriminalization law (PP, 2005-12) Priority 4 and specific focus expected due to financial pressures (CGDRS, 2010) Evaluating the effectiveness of interventions (Scottish drug strategy document 2008 ; drug strategy document 2008-2018) Treatment responses Scientific evaluation in prevention (BFPN, 2001 Promising medicines and new therapeutic strategies (FGP, Promising medications (DPA, 2011) Transcranic magnetic Effectiveness and harmfulness of prescribing heroin on medical ground to any type of addict (DWP, 1996) Assessing the impact of the decriminalization law(PP, 2005-12) Priority 4 and specific focus expected due to financial pressures (CGDRS, 2010)
research_policy_and_funding_programmes.docx